Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

118.47
BATS BZX Real-Time Price
As of 1:27pm ET
 -0.40 / -0.34%
Today’s Change
93.05
Today|||52-Week Range
127.00
-1.08%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Celgene have a median target of 138.00, with a high estimate of 162.00 and a low estimate of 92.00. The median estimate represents a +16.49% increase from the last price of 118.47.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Buy stock in Celgene. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.59
Sales
$3.0B
Reporting Date
Feb 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.43%
 
 
 
 
 
 
Growthannually 25.60%
 
 
 
 
 
 

Sales

Growthquarterly 1.72%
 
 
 
 
 
 
Growthannually 21.90%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.